Impact of Amphiphilic Balance on Nano–Bio Interactions of Peptide Amphiphile Nanostructures
Source abstract
Abstract
Self-assembled peptide amphiphile (PA)-based nanostructures are promising biomaterials with their biocompatibility and highly tunable physical and chemical properties. Despite this promise, the interactions of PA nanostructures with biological systems have remained largely unexplored. Here, we investigate nano-bio interactions of self-assembled PA nanostructures using a series of PAs with varying amphiphilicities, achieved by tuning the hydrophilicity of the peptide backbone and payloads attached to them. We show that, while PAs with hydrophilic peptide backbones and payloads mostly disassembled in blood plasma, increasing overall hydrophobicity improved their stability. We also report that disassembled PAs can bind to blood biomolecules and binding shifted from albumin to lipoproteins with increasing hydrophobicity. In addition, we show that the membrane-binding affinity of PAs increases with increasing PA hydrophobicity, which also induces membrane disruption and cytotoxicity. The results of this study highlight the critical role of the overall amphiphilic balance of PAs on their interactions with biological molecules and cell membranes.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
CEDAR, Knight Cancer Institute, School of Medicine
Oregon Health & Science University
Department of Biomedical Engineering, School of Medicine
Division of Oncological Sciences, Knight Cancer Institute, School of Medicine
Funding
Cancer Early Detection Advanced Research Center, Knight Cancer Institute, Oregon Health and Science University · National Institute of Neurological Disorders and Stroke · National Institute of Biomedical Imaging and Bioengineering
References (56)
Show source-provided references
1. 10.1021/acs.chemrev.1c0008910.1021/acs.chemrev.1c00089 ↗
2. 10.1021/acs.accounts.7b0029710.1021/acs.accounts.7b00297 ↗
3. 10.1021/acs.chemrev.1c0071210.1021/acs.chemrev.1c00712 ↗
4. 10.1039/c7cs00735c10.1039/c7cs00735c ↗
5. 10.1021/acs.biomac.7b0076410.1021/acs.biomac.7b00764 ↗
6. 10.1021/acs.accounts.3c0059210.1021/acs.accounts.3c00592 ↗
7. 10.1021/acs.nanolett.1c0173710.1021/acs.nanolett.1c01737 ↗
8. 10.1038/s41570-020-0215-y10.1038/s41570-020-0215-y ↗
9. 10.1021/nl202220q10.1021/nl202220q ↗
10. 10.1002/cbic.20230083110.1002/cbic.202300831 ↗
11. 10.1021/jacs.1c0613310.1021/jacs.1c06133 ↗
12. 10.1021/nl802813f10.1021/nl802813f ↗
13. 10.1021/acs.nanolett.5c0648110.1021/acs.nanolett.5c06481 ↗
14. 10.1021/acs.nanolett.5b0331310.1021/acs.nanolett.5b03313 ↗
15. 10.1039/b919446k10.1039/b919446k ↗
16. 10.1002/anie.20120294710.1002/anie.201202947 ↗
17. 10.1021/la300335510.1021/la3003355 ↗
18. 10.1002/adma.20250935910.1002/adma.202509359 ↗
19. 10.1002/smll.20251207310.1002/smll.202512073 ↗
20. 10.1016/j.jconrel.2011.09.06910.1016/j.jconrel.2011.09.069 ↗
21. 10.1021/acs.molpharmaceut.1c0004610.1021/acs.molpharmaceut.1c00046 ↗
22. 10.1021/acs.bioconjchem.9b0077110.1021/acs.bioconjchem.9b00771 ↗
23. 10.1021/acs.molpharmaceut.7b0095210.1021/acs.molpharmaceut.7b00952 ↗
24. 10.1016/j.addr.2016.04.03010.1016/j.addr.2016.04.030 ↗
25. 10.1016/j.addr.2020.08.00310.1016/j.addr.2020.08.003 ↗
26. 10.1016/j.addr.2016.04.02010.1016/j.addr.2016.04.020 ↗
27. 10.1038/nbt133910.1038/nbt1339 ↗
28. 10.1021/ar200017e10.1021/ar200017e ↗
29. 10.1021/mp100193h10.1021/mp100193h ↗
30. 10.1021/bi802356k10.1021/bi802356k ↗
31. 10.1371/journal.pone.005461110.1371/journal.pone.0054611 ↗
32. 10.1021/acs.jmedchem.2c0102110.1021/acs.jmedchem.2c01021 ↗
33. 10.1016/j.mam.2011.12.00210.1016/j.mam.2011.12.002 ↗
34. 10.1016/j.bcp.2026.11784610.1016/j.bcp.2026.117846 ↗
35. 10.1038/ncomms1609210.1038/ncomms16092 ↗
36. 10.1002/advs.20220161410.1002/advs.202201614 ↗
37. 10.1038/ncomms1567810.1038/ncomms15678 ↗
38. 10.1042/bj312072510.1042/bj3120725 ↗
39. 10.1023/b:pham.0000036926.54824.3710.1023/b:pham.0000036926.54824.37 ↗
40. 10.1021/acs.jmedchem.5b0072610.1021/acs.jmedchem.5b00726 ↗
41. 10.1038/nature1297810.1038/nature12978 ↗
42. 10.1021/acs.langmuir.9b0183710.1021/acs.langmuir.9b01837 ↗
43. 10.1021/acs.jpcb.5c0073710.1021/acs.jpcb.5c00737 ↗
44. 10.1021/am501673x10.1021/am501673x ↗
45. 10.1021/ma200675w10.1021/ma200675w ↗
46. 10.1111/j.1747-0285.2007.00610.x10.1111/j.1747-0285.2007.00610.x ↗
47. 10.1016/j.jconrel.2015.10.02910.1016/j.jconrel.2015.10.029 ↗
48. 10.1021/acs.chemrev.6b0000110.1021/acs.chemrev.6b00001 ↗
49. 10.1021/acs.jpclett.1c0373510.1021/acs.jpclett.1c03735 ↗
50. 10.1080/02652048.2024.238913510.1080/02652048.2024.2389135 ↗
51. 10.1016/j.chemphyslip.2008.04.00610.1016/j.chemphyslip.2008.04.006 ↗
52. 10.1021/acs.jpclett.5b0173910.1021/acs.jpclett.5b01739 ↗
53. 10.1016/j.bbamem.2006.02.02110.1016/j.bbamem.2006.02.021 ↗
54. 10.1016/j.bpj.2011.12.02910.1016/j.bpj.2011.12.029 ↗
55. 10.1039/c3tb20139b10.1039/c3tb20139b ↗
56. 10.1021/am404860q10.1021/am404860q ↗